Ondine Biomedical to use AIM capital access window for fundraise
Ondine Biomedical said it intends to use AIM’s new Capital Access Window in connection with a proposed equity capital raise and retail offer. The company said the pause in trading is voluntary and will remain until a further announcement on the fundraise results.